Description
BPC-157 / TB-500 20 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide blend supplied as a 20 mg total sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | BPC-157 / TB-500 |
| Supplier | Opti-Gen Peptides |
| Contents | 20 mg total per vial (ratio on lot COA) |
| Component A | BPC-157 — pentadecapeptide GEPPPGKPADDAGLV (CAS 137525-51-0) |
| Component B | TB-500 — thymosin β4–related peptide (full 43-aa Tβ4 CAS 77591-33-4 or short fragment; confirm COA) |
| Intended use | Laboratory / in-vitro research only |
Two separate single-peptide listings are not a substitute for confirming this blend’s COA.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
BPC-157 10mg is a synthetic fragment of body-protection compound from gastric-juice protein work associated with Sikiric and colleagues. Papers describe cell and animal assay models. FDA compounding communications have flagged BPC-157. That is regulatory context, not a use instruction.
TB-500 10 is a catalogue name for thymosin β4 or a short actin-binding fragment. Tβ4 papers concern G-actin / cell-motility assays. Literature on the 43-aa peptide must not be applied blindly to a fragment lot.
Combining the two names in shop marketing as a “healing stack” is not a claim for this listing. Both appear in WADA discussions. There is no UK marketing authorisation.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.